Eric Samorodnitsky, Ph.D.
Affiliations: | 2010 | Pennsylvania State University, State College, PA, United States |
Area:
Bioinformatics Biology, BiochemistryGoogle:
"Eric Samorodnitsky"Parents
Sign in to add mentor| B Franklin Pugh | grad student | 2010 | Penn State | |
| (Genome-wide modeling of transcription preinitiation complex disassembly mechanisms using chromatin immunoprecipitation data.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krook MA, Lenyo A, Wilberding M, et al. (2020) Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma. Molecular Cancer Therapeutics |
| Bonneville R, Krook MA, Chen HZ, et al. (2020) Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. Methods in Molecular Biology (Clifton, N.J.). 2055: 119-132 |
| Krook MA, Bonneville R, Chen HZ, et al. (2019) Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Cold Spring Harbor Molecular Case Studies. 5 |
| Krook MA, Barker H, Chen HZ, et al. (2019) Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases |
| Chen HZ, Bonneville R, Yu L, et al. (2019) Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy. Oncotarget. 10: 277-288 |
| Chen H, Bonneville R, Krook MA, et al. (2019) Abstract 748: Genomic characterization of recurrent small cell lung cancer through research autopsy reveals clonal diversity and candidate driver of chemoresistance Cancer Research |
| Krook MA, Lenyo AM, Wilberding MJ, et al. (2019) Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma Cancer Research. 79: 335-335 |
| Burkart J, Owen D, Shah MH, et al. (2018) Targeting Mutations in High-Grade Neuroendocrine Carcinoma of the Colon. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1035-1040 |
| Reeser JW, Martin D, Miya J, et al. (2017) Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors. The Journal of Molecular Diagnostics : Jmd |
| Datta J, Damodaran S, Parks H, et al. (2017) Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398. Molecular Cancer Therapeutics |